<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>41</viewCount><searchCount>0</searchCount></scores><additional><submitter>Liu Y</submitter><funding>Intramural NIH HHS</funding><funding>NIA NIH HHS</funding><pagination>126-32</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4688172</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>275 Pt 1</volume><pubmed_abstract>A high calorie diet (HCD) can impair hippocampal synaptic plasticity and cognitive function in animal models. Mitochondrial thioredoxin 2 (TRX-2) is critical for maintaining intracellular redox status, but whether it can protect against HCD-induced impairment of synaptic plasticity is unknown. We found that levels of TRX-2 are reduced in the hippocampus of wild type mice maintained for 8 months on a HCD, and that the mice on the HCD exhibit impaired hippocampal synaptic plasticity (long-term potentiation at CA1 synapses) and cognitive function (novel object recognition). Transgenic mice overexpressing human TRX-2 (hTRX-2) exhibit increased resistance to diquat-induced oxidative stress in peripheral tissues. However, neither the HCD nor hTRX-2 overexpression affected levels of lipid peroxidation products (F2 isoprostanes) in the hippocampus, and hTRX-2 transgenic mice were not protected against the adverse effects of the HCD on hippocampal synaptic plasticity and cognitive function. Our findings indicate that TRX-2 overexpression does not mitigate adverse effects of a HCD on synaptic plasticity, and also suggest that oxidative stress may not be a pivotal factor in the impairment of synaptic plasticity and cognitive function caused by HCDs.</pubmed_abstract><journal>Experimental neurology</journal><pubmed_title>Thidoredxin-2 overexpression fails to rescue chronic high calorie diet induced hippocampal dysfunction.</pubmed_title><pmcid>PMC4688172</pmcid><funding_grant_id>ZIA AG000315-14</funding_grant_id><funding_grant_id>ZIA AG000314-15</funding_grant_id><funding_grant_id>ZIA AG000315-15</funding_grant_id><funding_grant_id>ZIA AG000314-14</funding_grant_id><funding_grant_id>AG000315-14</funding_grant_id><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Dong H</pubmed_authors><pubmed_authors>Strong R</pubmed_authors><pubmed_authors>Mattson MP</pubmed_authors><pubmed_authors>Cutler RG</pubmed_authors><view_count>41</view_count></additional><is_claimable>false</is_claimable><name>Thidoredxin-2 overexpression fails to rescue chronic high calorie diet induced hippocampal dysfunction.</name><description>A high calorie diet (HCD) can impair hippocampal synaptic plasticity and cognitive function in animal models. Mitochondrial thioredoxin 2 (TRX-2) is critical for maintaining intracellular redox status, but whether it can protect against HCD-induced impairment of synaptic plasticity is unknown. We found that levels of TRX-2 are reduced in the hippocampus of wild type mice maintained for 8 months on a HCD, and that the mice on the HCD exhibit impaired hippocampal synaptic plasticity (long-term potentiation at CA1 synapses) and cognitive function (novel object recognition). Transgenic mice overexpressing human TRX-2 (hTRX-2) exhibit increased resistance to diquat-induced oxidative stress in peripheral tissues. However, neither the HCD nor hTRX-2 overexpression affected levels of lipid peroxidation products (F2 isoprostanes) in the hippocampus, and hTRX-2 transgenic mice were not protected against the adverse effects of the HCD on hippocampal synaptic plasticity and cognitive function. Our findings indicate that TRX-2 overexpression does not mitigate adverse effects of a HCD on synaptic plasticity, and also suggest that oxidative stress may not be a pivotal factor in the impairment of synaptic plasticity and cognitive function caused by HCDs.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jan</publication><modification>2020-11-19T08:42:31Z</modification><creation>2019-03-27T02:05:39Z</creation></dates><accession>S-EPMC4688172</accession><cross_references><pubmed>26476179</pubmed><doi>10.1016/j.expneurol.2015.10.002</doi></cross_references></HashMap>